Back

Real world experience of introducing the new heart failure drug LCZ 696 in ambulatory care setting

1 May 2017 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Renin-angiotensin-aldosterone antagonists Renin-angiotensin-aldosterone antagonists HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Ms Laura O'connor

Beaumont Hospital, Dublin 9 (Ireland)

2 More presentations in this session

Presentation thumbnail
Assistant Professor S. Jang (Daegu, KR)
Abstract Slides
Presentation thumbnail
Doctor N. Sapojnic (Chisinau, MD)
Abstract

Access the full session

Session thumbnail
Poster session 3 - Renin-angiotensin-aldosterone antagonists

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Real-world implementation of guideline-directed treatment in advanced heart failure: single center experience
20 May 2023
thumbnail
Congress Session
The power of now: a focus on SGLT2 inhibitors for heart failure in the hospital
17 May 2025
thumbnail
Congress Presentation
Evaluating tolerability and patient outcomes of sacubitril/valsartan for the management of heart failure with reduced ejection fraction within a pharmacist led clinic at a cardiovascular tertiary cent
29 June 2021
thumbnail
Congress Session
Pulmonary hypertension & acute arrhythmias are cardiac care challenges. How to effectively treat them with drugs
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources